Skip to content

Early Identification and Prognosis Prediction of Sepsis Through Multiomics

Early Identification and Prognosis Prediction of Sepsis Through Multiomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05305469
Acronym
EIPPSM
Enrollment
900
Registered
2022-03-31
Start date
2022-01-01
Completion date
2025-12-31
Last updated
2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

Prognosis, Inflammation, Immune, Multiomics, Machine learning

Brief summary

This study aims to integrate multi-omics data and clinical indicators to reveal pathogen-specific molecular patterns in patients with sepsis and establish prognostic prediction models through multiple machine learning algorithms.

Detailed description

This study aims to quantify the plasma metabolome, single nucleotide polymorphisms (SNPs) of exons and immunocytokines of septic patients with different pathogen infections and prognostic outcomes. Multi-omics data, cytokines, and clinical indicators will be integrated through multiple machine learning algorithms to reveal pathogen-specific molecular patterns and multi-dimensional prognostic prediction models.

Interventions

None listed

Sponsors

Yantai Yuhuangding Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with sepsis or septic shock who meet the diagnostic criteria (2016 sepsis 3.0 standard); * Age 18~85 years old.

Exclusion criteria

* ICU stay of the subjects less than 72 hours; * Female subjects who are pregnant; * The subjects not sure if infected; * The subjects performed CPR; * The subjects suffer from chronic renal disease; * The subjects with incomplete clinical data.

Design outcomes

Primary

MeasureTime frameDescription
Pathogen-specific patternsMarch 2022 - December 2023To elucidate the unique infection pathogen-specific molecular patterns in septic patients

Secondary

MeasureTime frameDescription
Prognostic prediction modelsMarch 2022 - December 2024To establish the models using multi-omics data to predict the prognosis of sepsis

Countries

China

Contacts

Primary ContactJing Wang
wangjinghehe@sina.com8605356691999

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026